Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTHrP in Postmenopausal Osteoporosis
NCT00021827Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Jun 1999
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of parathyroid hormone-related protein in osteoporosis (2 arms), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Primary endpoint: Lumbar spine Bone Mineral Density at 3 months. Started Jun 1999; status: completed.
02
Drugs
parathyroid hormone-related protein
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00021827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00021827.